ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops

Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children

Tetra Bio-Pharma appoints CFO

Auld is a seasoned Financial Executive with over 30 years of relevant experience

Mezzion Pharma receives clear FDA path forward for the approval of Udenafil for single ventricle heart disease

Glenmark Pharma reports revenue growth of 5.6% YoY in Q4

Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022

DFE Pharma opens its new Center of Excellence in Hyderabad, India

The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs

Torrent Pharma acquires four brands from Dr Reddy’s

The integration and transition of the brands are expected to be completed by June 2022.

Sun Pharma acquires Uractiv portfolio from Fiterman Pharma in Romania

The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential

Strides Pharma Science Q4FY22 consolidated PAT at Rs. 29.21 Cr

The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.

Eugia Pharma receives USFDA approval for Pemetrexed

Pemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)

Dr. Reddy's and Senores Pharmaceuticals launches Ketorolac Tromethamine tablets in the U.S. market

The Toradol tablets, 10 mg brand and generic had U.S. sales of approximately US $ 16.8 million MAT for the most recent twelve months ending in March 2022 according to IQVIA